Cargando…
Heat Shock Proteins: Conditional Mediators of Inflammation in Tumor Immunity
Heat shock protein (HSP)-based anticancer vaccines have undergone successful preclinical testing and are now entering clinical trial. Questions still remain, however regarding the immunological properties of HSPs. It is now accepted that many of the HSPs participate in tumor immunity, at least in pa...
Autores principales: | Calderwood, Stuart K., Murshid, Ayesha, Gong, Jianlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342006/ https://www.ncbi.nlm.nih.gov/pubmed/22566956 http://dx.doi.org/10.3389/fimmu.2012.00075 |
Ejemplares similares
-
The Role of Heat Shock Proteins in Antigen Cross Presentation
por: Murshid, Ayesha, et al.
Publicado: (2012) -
Extracellular HSPs: The Complicated Roles of Extracellular HSPs in Immunity
por: Calderwood, Stuart K., et al.
Publicado: (2016) -
Immunological Outcomes Mediated Upon Binding of Heat Shock Proteins to Scavenger Receptors SCARF1 and LOX-1, and Endocytosis by Mononuclear Phagocytes
por: Murshid, Ayesha, et al.
Publicado: (2020) -
Heat Shock Proteins, Autoimmunity, and Cancer Treatment
por: Calderwood, Stuart K., et al.
Publicado: (2012) -
Editorial: HSPs—Ambiguous Mediators of Immunity
por: Calderwood, Stuart K., et al.
Publicado: (2016)